ChinaBio Partnering Forum 2016 returning to Suzhou, China's life science hub, May 18–19 May 2016

The event will bring together biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies to capitalize on this high-growth potential.

"China is transforming into an innovation-based economy," said Greg B. Scott, Founder of ChinaBio Group. "Suzhou BioBay has aggressively fostered innovation in medical devices, pharmaceuticals, and diagnostics, as well as research-related services. Many of the companies as well as companies from all over China are eager to partner with western companies."

Hengrui, a leading developer of novel cancer therapeutics in China, is a regular attendee and presenter at ChinaBio Partnering Forum. "At ChinaBio, we meet many companies from here in China as well as from the US and Europe, and we can discuss possible collaborations to help bring new medicines to the market," said Lianshan Zhang, President of Global R&D at Hengrui.

Innovative companies, organizations and researchers interested in partnering their technologies or products, initiating strategic alliances, or tapping into the financing network in China may apply to present at the event.

partneringONE is EBD Group's sophisticated, web-based partnering system that enables event delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative startups.